BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 30291675)

  • 1. Adenosine deaminase inhibition suppresses progression of 4T1 murine breast cancer by adenosine receptor-dependent mechanisms.
    Kutryb-Zajac B; Koszalka P; Mierzejewska P; Bulinska A; Zabielska MA; Brodzik K; Skrzypkowska A; Zelazek L; Pelikant-Malecka I; Slominska EM; Smolenski RT
    J Cell Mol Med; 2018 Dec; 22(12):5939-5954. PubMed ID: 30291675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of LPS-stimulated ecto-adenosine deaminase attenuates endothelial cell activation.
    Kutryb-Zajac B; Mierzejewska P; Sucajtys-Szulc E; Bulinska A; Zabielska MA; Jablonska P; Serocki M; Koszalka P; Milczarek R; Jasztal A; Bartoszewski R; Chlopicki S; Slominska EM; Smolenski RT
    J Mol Cell Cardiol; 2019 Mar; 128():62-76. PubMed ID: 30641086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased activity of vascular adenosine deaminase in atherosclerosis and therapeutic potential of its inhibition.
    Kutryb-Zajac B; Mateuszuk L; Zukowska P; Jasztal A; Zabielska MA; Toczek M; Jablonska P; Zakrzewska A; Sitek B; Rogowski J; Lango R; Slominska EM; Chlopicki S; Smolenski RT
    Cardiovasc Res; 2016 Nov; 112(2):590-605. PubMed ID: 28513806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid determination of adenosine deaminase kinetics using fast-scan cyclic voltammetry.
    Xu Y; Venton BJ
    Phys Chem Chem Phys; 2010 Sep; 12(34):10027-32. PubMed ID: 20577678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal inhibition of mouse mammary gland cancer metastasis by CORM-A1 and DETA/NO combination therapy.
    Porshneva K; Papiernik D; Psurski M; Łupicka-Słowik A; Matkowski R; Ekiert M; Nowak M; Jarosz J; Banach J; Milczarek M; Goszczyński TM; Sieńczyk M; Wietrzyk J
    Theranostics; 2019; 9(13):3918-3939. PubMed ID: 31281522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rat brain adenosine deaminase after 2'-deoxycoformycin administration: biochemical properties and evidence for reduced enzyme levels detected by 2'-[3H]deoxycoformycin ligand binding.
    Padua RA; Geiger JD; Delaney SM; Nagy JI
    J Neurochem; 1992 Feb; 58(2):421-9. PubMed ID: 1729390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2'-Deoxycoformycin inhibition of adenosine deaminase in rat brain: in vivo and in vitro analysis of specificity, potency, and enzyme recovery.
    Padua R; Geiger JD; Dambock S; Nagy JI
    J Neurochem; 1990 Apr; 54(4):1169-78. PubMed ID: 2179470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine deaminase inhibition enhances the inotropic response mediated by A1 adenosine receptor in hyperthyroid guinea pig atrium.
    Kemeny-Beke A; Jakab A; Zsuga J; Vecsernyes M; Karsai D; Pasztor F; Grenczer M; Szentmiklosi AJ; Berta A; Gesztelyi R
    Pharmacol Res; 2007 Aug; 56(2):124-31. PubMed ID: 17574432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An unusual nicotinamide derivative, 4-pyridone-3-carboxamide ribonucleoside (4PYR), is a novel endothelial toxin and oncometabolite.
    Mierzejewska P; Kunc M; Zabielska-Kaczorowska MA; Kutryb-Zajac B; Pelikant-Malecka I; Braczko A; Jablonska P; Romaszko P; Koszalka P; Szade J; Smolenski RT; Slominska EM
    Exp Mol Med; 2021 Sep; 53(9):1402-1412. PubMed ID: 34580423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo effects of 2'-deoxycoformycin (Pentostatin) on tumour cells from human gammadelta+ T-cell malignancies.
    Aldinucci D; Poletto D; Zagonel V; Rupolo M; Degan M; Nanni P; Gattei V; Pinto A
    Br J Haematol; 2000 Jul; 110(1):188-96. PubMed ID: 10930997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antinociception by adenosine analogs and inhibitors of adenosine metabolism in an inflammatory thermal hyperalgesia model in the rat.
    Poon A; Sawynok J
    Pain; 1998 Feb; 74(2-3):235-45. PubMed ID: 9520238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine inhibits tumor cell invasion via receptor-independent mechanisms.
    Virtanen SS; Kukkonen-Macchi A; Vainio M; Elima K; Härkönen PL; Jalkanen S; Yegutkin GG
    Mol Cancer Res; 2014 Dec; 12(12):1863-74. PubMed ID: 25080434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spinally-mediated antinociception is induced in mice by an adenosine kinase-, but not by an adenosine deaminase-, inhibitor.
    Keil GJ; DeLander GE
    Life Sci; 1992; 51(19):PL171-6. PubMed ID: 1435056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conversion of viramidine to ribavirin in vivo by adenosine deaminase and its inhibition by 2'-deoxycoformycin.
    Wu JZ; Yeh LT; Lin CC; Hong Z
    Antivir Chem Chemother; 2006; 17(1):33-9. PubMed ID: 16542004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolomics-driven identification of adenosine deaminase as therapeutic target in a mouse model of Parkinson's disease.
    Huang W; Xu Y; Zhang Y; Zhang P; Zhang Q; Zhang Z; Xu F
    J Neurochem; 2019 Aug; 150(3):282-295. PubMed ID: 31121068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Animal model for immune dysfunction associated with adenosine deaminase deficiency.
    Tedde A; Balis ME; Ikehara S; Pahwa R; Good RA; Trotta PP
    Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4899-903. PubMed ID: 6968908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early and late endothelial response in breast cancer metastasis in mice: simultaneous quantification of endothelial biomarkers using a mass spectrometry-based method.
    Suraj J; Kurpińska A; Zakrzewska A; Sternak M; Stojak M; Jasztal A; Walczak M; Chlopicki S
    Dis Model Mech; 2019 Mar; 12(3):. PubMed ID: 30683749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of deoxycoformycin and Val-boroPro on the associated catalytic activities of lymphocyte CD26 and ecto-adenosine deaminase.
    Jeanfavre DD; Woska JR; Pargellis CA; Kennedy CA; Prendergast J; Stearns C; Reilly PL; Barton RW; Bormann BJ
    Biochem Pharmacol; 1996 Dec; 52(11):1757-65. PubMed ID: 8986139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutagenesis of human adenosine deaminase to active forms that partially resist inhibition by pentostatin.
    Ibrahim MM; Weber IT; Knudsen TB
    Biochem Biophys Res Commun; 1995 Apr; 209(2):407-16. PubMed ID: 7733907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine deaminase inhibition attenuates microvascular dysfunction and improves survival in sepsis.
    Cohen ES; Law WR; Easington CR; Cruz KQ; Nardulli BA; Balk RA; Parrillo JE; Hollenberg SM
    Am J Respir Crit Care Med; 2002 Jul; 166(1):16-20. PubMed ID: 12091165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.